Hutch News

Hutch News

Stories tagged 'skin cancer'

Hutch science featured at world's premier cancer immunotherapy meeting

Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer

Nov. 14, 2018 | By Susan Keown / Fred Hutch News Service

Fred Hutch's Drs. Philip Greenberg, Kristin Anderson and Kelly Paulson were honored Nov. 10 at the annual meeting of the Society for Immunotherapy of Cancer in Washington, D.C.

View story >


Researchers identify new way skin stops tumor growth

‘Oncogene-induced differentiation’ joins two other strategies for counteracting potentially cancer-causing DNA changes

Oct. 22, 2018 | by Sabrina Richards / Fred Hutch News Service

Dr. Slobodan Berjona and colleagues at Fred Hutch have identified a new way that skin stops tumor growth: oncogene-induced differentiation.

View story >


Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show

June 4, 2018 | by Susan Keown / Fred Hutch News Service

Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.

View story >


7 skin cancer myths — debunked

Experts take on base tans and other ‘complete baloney’ standing in the way of skin health

Aug. 2, 2017 | By Susan Keown / Fred Hutch News Service

From indoor tanning to sunscreen use: Lower your risk of skin cancer by confronting these myths head on.

View story >


Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer

Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma

March 24, 2017 | by Susan Keown / Fred Hutch News Service

Tom Judd's metastatic Merkel cell carcinoma nearly took his life. But then he enrolled on a trial of an experimental immunotherapy drug.

View story >


Scratching the surface of a rare skin cancer

Immune-boosting therapy shows promise for advanced Merkel cell carcinoma

Oct. 6, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

Skin cancer researcher Dr. Paul Nghiem is leading a clinical trial testing the immunotherapy drug pembrolizumab for patients with advanced Merkel cell carcinoma, a rare and aggressive skin cancer. Early results from the trial are showing great promise for these patients.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.